Spain – Various medicinal products – Suministro del medicamento cuyo Principio Activo es VUTRISIRAN para el Complejo Asi
Gerencia de Atención Especializada de Salamanca awarded €427K to ALNYLAM PHARMACEUTICALS SPAIN, S.L. for Construction & Public Works in July 2025 — one of 65 awards this buyer has made, in line with its typical award size.
Buying agency
Gerencia de Atención Especializada de SalamancaWinning supplier
ALNYLAM PHARMACEUTICALS SPAIN, S.L.Contract description
Spain – Various medicinal products – Suministro del medicamento cuyo Principio Activo es VUTRISIRAN para el Complejo Asistencial Universitario de Salamanca.
Related awards · Gerencia de Atención Especializada de Salamanca
65 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-768315-2024WERFEN ESPAÑA, S.A.U.€2.2M16 Dec 2024 Construction
- ocds-ted-802067-2025HORI-HORI, S.A.€1.8M03 Dec 2025 Professional Services
- ocds-ted-153119-2026JANSSEN-CILAG, S.A.€1.8M05 Mar 2026 Construction
Other wins · ALNYLAM PHARMACEUTICALS SPAIN, S.L.
43 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-675384-2024Servicio Andaluz de Salud. Hospital Universitario Juan Ramón Jiménez€14.8M06 Nov 2024 Construction
- ocds-ted-447588-2025Fundación de Gestión Sanitaria del Hospital de la Santa Creu i Sant Pau€8.4M09 Jul 2025 Construction
- ocds-ted-158957-2024OSAKIDETZA - Servicio Vasco de Salud - Organización Central€7.3M15 Mar 2024 Construction
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Gerencia de Atención Especializada de Salamanca and ALNYLAM PHARMACEUTICALS SPAIN, S.L. — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back